Spusoft(Erdosteine 300 mg)

Therapeutic Group: Mucolytic drug

Presentation

Spusoft Capsule: Each capsule contains Erdosteine INN 300 mg

Description

Erdosteine is a mucolytic drug. It is a prodrug and it becomes active after metabolism. It acts by reducing the viscosity of mucus. In addition, it has asignificant antioxidant action and it inhibits bacterial adhesion to epithelial cells.

Indications

Erdosteine is a mucolytic drug used in the treatment of acute and chronic respiratory diseases. It also improves the symptoms associated with short episodes of chronic

bronchitis.

Dosage & Administration

The usual dose of elderly patients and adults above 18 years is 1 capsule twice daily. The maximum duration of therapy is 10 days.

Side Effects

Common side effect is epigastric pain. Other side effects include headache, cold, difficulty in breathing, taste alterations, nausea, vomiting, diarrhea, angioedema and
other skin allergic reactions

Precautions

It should be used with caution in mild liver failure. In that case, should not exceed a dose of 300 mg per day

Use in Pregnancy & Lactation

The use of Erdosteine in pregnant or breast-feeding women is not recommended

Storage

Do not store above 30 0C. Keep away from light and out of the reach of children

Commercial Pack

Spusoft capsule: Each box contains 2 blister strips of 10 capsules